Xiong_1995_Pharmacol.Biochem.Behav_51_415

Reference

Title : Effect of huperzine A, a novel acetylcholinesterase inhibitor, on radial maze performance in rats - Xiong_1995_Pharmacol.Biochem.Behav_51_415
Author(s) : Xiong ZQ , Tang XC
Ref : Pharmacology, Biochemistry & Behavior , 51 :415 , 1995
Abstract :

Rats were trained to run in a spatial, radial arm maze using a procedure to determine two memory functions, working and reference memory. The muscarinic antagonist, not the nicotinic antagonist, impaired both working and reference memory of rats. Scopolamine (0.125, 0.15, and 0.2 mg/kg, IP, 30 min before a session) significantly impaired choice accuracy in the eight-arm maze. In contrast, mecamylamine (5, 10, and 15 mg/kg) did not affect the performance. Huperzine A (0.1, 0.2, and 0.3 mg/kg, IP, 30 min before testing) and physostigmine (0.3 mg/kg, IP, 20 min before testing) could reverse scopolamine-induced deficits in the task. Chronic treatment with huperzine A (0.25 mg/kg, PO, once a day) for 8 consecutive days was as potent as acute treatment on attenuating the scopolamine-induced amnesia.

PubMedSearch : Xiong_1995_Pharmacol.Biochem.Behav_51_415
PubMedID: 7667362

Related information

Citations formats

Xiong ZQ, Tang XC (1995)
Effect of huperzine A, a novel acetylcholinesterase inhibitor, on radial maze performance in rats
Pharmacology, Biochemistry & Behavior 51 :415

Xiong ZQ, Tang XC (1995)
Pharmacology, Biochemistry & Behavior 51 :415